[Reuters] India's Supreme Court has barred Glenmark Pharmaceuticals from making and selling copies of U.S. drugmaker Merck's diabetes drugs Januvia and Janumet, according to a court document released on Friday. The court has, however, allowed ... Jutia Group, 1 week ago
Glenmark gets tentative FDA nod for generic psoriasis cream - Livemint.com, 2 weeks ago
Glenmark gets tentative USFDA nod for generic psoriasis cream - Hindu Business Line, 2 weeks ago
3 images for "glenmark generics inc"
Glenmark Pharmaceuticals on Wednesday said its US-based subsidiary Glenmark Generics Inc has agreed to settle the pricing investigation with the Texas Attorney General under the Texas Medicaid Fraud Prevention Act (TMFPA) by paying $25 million (around Rs 155 ...DNA, 1 month ago Glenmark's subsidiary to pay $25m to settle a pricing case The Financial Chronicle, 1 month ago Glenmark's subsidiary to pay $25 million to settle a pricing case Economic Times, 1 month ago Glenmark's subsidiary to pay $25 mn to settle a pricing case Smart Investor, 1 month ago
The US subsidiary of Glenmark Pharmaceuticals Ltd (GPL), Glenmark Generics Inc., USA, has entered into a settlement with the State of Texas, US, under which it would pay $25 million spread over a period of 16 quarters (four years) to the state. ...Hindu Business Line, 1 month ago
/PRNewswire/ --Eisai Inc. and Eisai Co., Ltd. have entered into a settlement agreement with Glenmark Pharmaceuticals, Ltd., Glenmark Generics Ltd., and Glenmark Generics, Inc.,USA("Glenmark"), to resolve their patent litigation relating to Eisai's ...FierceBiotech, 2 weeks ago Eisai Inc. And Glenmark Pharmaceuticals Reach Settlement Over Generic Version Of BANZEL (rufinamide) BioSpace, 3 weeks ago
More from: Reuters, Town Hall...and 27 other sources
Glaxosmithkline LLC, et al. v. Glenmark Generics Inc., USA, et al , C.A. Nos. 14-877LPSCJB; 14-878LPS-CJB, April 22, 2015. Burke, M. J. Report and Recommendation recommends granting in part and denying in part defendants motions to dismiss. ...JD Supra, 3 weeks ago
Glenmark Pharmaceuticals is currently trading at Rs. 889.90, up by 45.50 points or 5.39% from its previous closing of Rs. 844.40 on the BSE. The scrip opened at Rs. 878.50 and has touched a high and low of Rs. 892.00 and Rs. 871.15 respectively.Indian-Commodity, 1 month ago
Related to : Glenmark Pharmaceuticals Ltd Glenmark Pharmaceuticals Ltd BSE 08 Apr 15 | 11:41 AM 883.00 38.6 (4.57%) NSE 08 Apr 15 | 11:25 AM 883.95 39.75 (4.71%) Shares of Glenmark Pharmaceuticals rallied 6% to Rs 895 on the ...Smart Investor, 1 month ago Glenmark hits new high, up 6% on CCEA nod to hike FII limit Moneycontrol.com, 1 month ago
P The company will pay USD 11.25 million each to the US federal government and the Texas state administration in 16 tranches spread over four years, besides paying USD 2.5 million as the cost of litigation. "Our subsidiary Glenmark Generics Inc., ...Moneycontrol.com, 1 month ago Glenmark's subsidiary to pay USD 25 million to settle a pricing case Jagran Post, 1 month ago
Email this Print Related to : Glenmark Pharmaceuticals Ltd Glenmark Pharmaceuticals Ltd BSE 01 Jan 70 | 05:30 AM 0.00 0 (0%) NSE 08 Apr 15 | 10:00 AM 890.15 45.95 (5.44%) Shares of Glenmark Pharmaceuticals has rallied 6% to Rs ...Smart Investor, 1 month ago
Glenmark Pharmaceuticals is currently trading at Rs. 849.00, up by 1.05 points or 0.12% from its previous closing of Rs. 847.95 on the BSE. The scrip opened at Rs. 854.00 and has touched a high and low of Rs. 857.65 and Rs. 836.05 respectively. So ...Indian-Commodity, 1 month ago
on your WebpageAdd Widget >Get your members hooked!